GENSURE 2019-NCOV ANTIGEN RAPID TEST (LATERAL FLOW) IS AN IMMUNOCHROMATOGRAPHIC ASSAY FOR THE RAPID IDENTIFICATION OF THE NEW CORONAVIRUS (2019-NCOV) ARISING FROM ANTIGENS EXTRACTED FROM SAMPLES TAKEN VIA NASAL AND NOSOPHARYNGAL SWABS.

DETECTION TIME 10/15 MINUTES.

THE TEST IS EASY TO PERFORM AND REQUIRES A FEW STEPS TO PERFORM.

NO CONTAINMENT OR PREVENTION MEASURES SUCH AS BIOHAZARD HOODS ARE NECESSARY.

IT IS POSSIBLE TO ANALYZE SAMPLES STORED IN VIRAL TRANSPORT MEDIA WITH OR WITHOUT ACTIVATOR.

FOR PROFESSIONAL USE ONLY

NASAL OR NOSOPHARYNGAL SWABS ARE PACKAGED INDIVIDUALLY

LATEX FREE, PHTHALATE FREE, APYROGEN.

FREE FROM PCR INHIBITORS FOR THE RESEARCH OF SARS COV2

BELONG TO THE WANTED PATHOGENS

SENSITIVITY: 96.6% (93.29% ~ 98.84%)

SPECIFICITY: 100% (9􏰁, 97% 􏰂100%)

TOTAL AGREED: 9􏰁, 91% (97.63% ~ 99.60%) LOD: 96.86%